Search:
 
BIOTHERAPEUTICS

 


USV has been successful in developing therapeutic proteins and peptides by recombinant* and chemical synthesis processes. These include hGH, Enterokinase, hG-CSF, Teriparatide and PDGF-BB which have been developed using recombinant DNA (rDNA) technology and Eptifibatide and Bivalirudin, by chemical synthesis.

Product Status
  Eptifibatide   Commercialized
  Enterokinase   Commercialized
  Bivalirudin   Commercialized
  rhGH   Clinicals
  PDGF-BB   Clinicals
  Teriparatide   Clinicals
  rhG-CSF   Pre-clinicals
  PEG-GCSF   Pre-clinicals
  PEG-IFN   Scale-up
 
* We are open to third party product development using our expression platforms. Contact us for details.

Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.

 
 
Current Product Range
Eptifibatide
Enterokinase
Bivalirudin
Contact Us